SYDNEY, Oct. 27, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of new data from an ongoing research collaboration with the Huntsman Cancer Institute at the University of Utah…
Related Articles
News
Bucked Up® Turns 10 With Its Biggest Summer Sale to Celebrate
June 12, 2026
UCBN
News, Syndication
Comments Off on Bucked Up® Turns 10 With Its Biggest Summer Sale to Celebrate
50% off sitewide. Four days only. A decade in the making. OREM, Utah, June 12, 2026 /PRNewswire/ — Bucked Up®, one of the fastest-growing supplement, beverage, and lifestyle brands in the U.S., today announced its […]
News
Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025
April 7, 2025
UCBN
News, Syndication
Comments Off on Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended […]
News
Ryan and Ashley Smith Foundation Gives $20 Million to Support Pediatric Cancer Research
November 8, 2022
UCBN
News
Comments Off on Ryan and Ashley Smith Foundation Gives $20 Million to Support Pediatric Cancer Research
SALT LAKE CITY–(BUSINESS WIRE)–The Ryan and Ashley Smith Foundation today announced a $20 million donation to Utah’s Intermountain Primary Children’s Hospital, a 100-year-old, top-ranked pediatric hospital. The money will help power groundbreaking pediatric cancer research […]
